Biotech Values

[rfj1862]

Re: BTM

I tend to agree that newsletters are useless. The record for Medical Technology Stock Letter (MTSL) is not much better. Sure, they have had years where they've made 120%+, but they've also had -70% years as well. And they tend to sit on clear losers like Allos Therapeutics. Following newsletter recommendations blindly is foolish.

Nevertheless, I'll take my ideas from anywhere--newsletters, brokerage reports, the guy that types in all caps on Yahoo. As long as you do your own DD, any and all ideas are interesting.

I wish I-Hub members would be more forthcoming about their picks--even better, RMFs for your picks would be great.

For myself, I'm looking at THLD. If I decide it is worth it, I'll generate an RMF.

John